2021
DOI: 10.1016/j.ejon.2021.101974
|View full text |Cite
|
Sign up to set email alerts
|

Interprofessional clinical pathway program effects on patient outcomes in the setting of neutropenic fever: An integrative review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…However, this ethonursing study found that this antibiotic would not be prescribed for the patients if the infection has not to occur. A recent integrative review by Dunnack and Montano revealed that multiple health professional who works together towards standardize implementation for neutropenic fever will improve the patient's outcomes, including reducing antibiotic duration, deaths, cost, and length of stay (Dunnack and Montano, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…However, this ethonursing study found that this antibiotic would not be prescribed for the patients if the infection has not to occur. A recent integrative review by Dunnack and Montano revealed that multiple health professional who works together towards standardize implementation for neutropenic fever will improve the patient's outcomes, including reducing antibiotic duration, deaths, cost, and length of stay (Dunnack and Montano, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…After the implementation of the clinical pathway, it was found that the cost of hospitalization, surgery, treatment, treatment, and medical consumables even patients had a shorter length of hospital stay and a signi cant reduction in the duration of antibiotic use, thus positively impacting patient clinical outcomes. 10,11 Research in China found the introduction of clinical pathways can shorten patient care days by an average difference of two days. 12 In hospitalized patients with a diagnosis of Community Acquired Pneumonia (CAP), the average LOS in the pre-clinical pathway period is 5 days (range 3-16) and in the post-clinical pathway period of 4 days (range 2-14).…”
Section: Discussionmentioning
confidence: 99%